Omicron Boosters Available From Next Month

"); jQuery("#212 h3").html("

Related News Programmes

"); jQuery(document).ready(function() { jwplayer.key='EKOtdBrvhiKxeOU807UIF56TaHWapYjKnFiG7ipl3gw='; var playerInstance = jwplayer("jquery_jwplayer_1"); playerInstance.setup({ file: "https://newsstatic.rthk.hk/audios/mfile_1677282_1_20221126100138.mp3", skin: { url: location.href.split('/', 4).join('/') + '/jwplayer/skin/rthk/five.css', name: 'five' }, hlshtml: true, width: "100%", height: 30, wmode: 'transparent', primary: navigator.userAgent.indexOf("Trident")>-1 ? "flash" : "html5", events: { onPlay: function(event) { dcsMultiTrack('DCS.dcsuri', 'https://news.rthk.hk/rthk/en/component/k2/1677282-20221126.mp3', 'WT.ti', ' Audio at newsfeed', 'WT.cg_n', '#rthknews', 'WT.cg_s', 'Multimedia','WT.es','https://news.rthk.hk/rthk/en/component/k2/1677282-20221126.htm', 'DCS.dcsqry', '' ); } } }); }); });

2022-11-26 HKT 09:22

Share this story

facebook

  • Omicron boosters available from next month

Booster shots that protect against both the highly-infectious Omicron variant, and the original Covid strain, will be available to the public from next month.

The government made the announcement after around 770,000 doses of the so-called bivalent shots arrived here on Friday. But the Secretary for the Civil Service, Ingrid Yeung, who is in charge of the Covid vaccination programme, said these BioNTech bivalent jabs would only be available as a fourth dose alternative.

"The bivalent vaccine is only for those who are having their fourth dose," she said. "Those who are having their first to third dose, they will not have this choice of the bivalent vaccine or the one that we have already been using."

Currently, the public can choose between the original BioNTech mRNA vaccine, marketed here as Comirnaty, and the Sinovac deactivated virus jab.

The government recommends two groups receive a fourth dose, namely people over 50 and anyone with a weak immune system. People under 50 can also get a fourth Covid shot on a voluntary basis.

The Government has procured a total of 1.9 million doses of the BioNTech bivalent mRNA vaccine. The remaining doses are expected by the end of the year.

mRNA vaccines are new type of vaccine that trigger the body to produce a protein which leads to an immune response.

RECENT NEWS

Plantos Agentic AI CFO Takes Aim At The SME Lending Gap

Planto, a leading financial technology company specialising in AI-driven banking solutions, officially unveiled its whi... Read more

Hong Kong And Indonesia Explore QR Payment Interoperability

Hong Kong and Indonesia are exploring QR payment interoperability between the two markets. The Hong Kong Monetary Autho... Read more

Who Raises The Alarm, If Synthetic Identity Fraud Has No Victim?

Synthetic identity fraud is one of the fastest-growing fraud types globally, where fraudsters fabricate a person who ne... Read more

SFC Hong Kong Strategic Action Plan Backs Citys Five-Year Plan

Hong Kong’s Securities and Futures Commission (SFC) has unveiled a strategic action plan. It supports the city’s Fi... Read more

Tencent Launches TenPayGo Payment App For Travellers In China

Tencent has launched TenPayGo, a payment app for overseas visitors to mainland China. ITHome (IT之家) reported that i... Read more

Deutsche Bank Deploys Agentic AI To Help Trace Client Wealth For KYC

Deutsche Bank Private Bank has launched an agentic AI tool to support Source of Wealth checks, part of its Know Your Cu... Read more